Hap Trading, LLC Novartis Ag Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $425,592 - $482,586	-4,600 Reduced 29.3%	11,100 $1.12 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $1.26 Million - $1.46 Million	15,700 New	15,700 $50,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $901,824 - $1.05 Million	-11,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $200,275 - $226,550	-2,500 Reduced 18.25%	11,200 $25,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $1.09 Million - $1.21 Million	13,700 New	13,700 $19,000
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $2.13 Million - $2.35 Million	-25,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $5 Million - $6.05 Million	-64,100 Reduced 71.94%	25,000 $122,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $5.04 Million - $5.59 Million	61,400 Added 221.66%	89,100 $60,000
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $1.46 Million - $1.64 Million	-18,000 Reduced 39.39%	27,700 $63,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $2.11 Million - $2.96 Million	29,900 Added 189.24%	45,700 $80,000
Q4 2019 Feb 11, 2020	BUY	$84.35 - $95.37 $126,524 - $143,055	1,500 Added 10.49%	15,800 $94,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $709,982 - $782,358	-8,300 Reduced 36.73%	14,300 $21,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $75,400 - $92,800	1,000 Added 4.63%	22,600 $130,000
Q1 2019 May 10, 2019	BUY	$75.32 - $86.15 $1.63 Million - $1.86 Million	21,600 New	21,600 $48,000
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $928,116 - $1.03 Million	-12,600 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $843,444 - $975,618	12,600 New	12,600 $27,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account